Median time of exposure to treatment: 3.5 years
In addition, there are new and innovative molecule types in the obesity pipeline, including monoclonal antibodies, antibody-drug conjugates, nanoparticle-drug conjugates, peptides, radiopharmaceuticals, recombinant proteins, and gene therapies, among others
GLP-1 medications affect appetite and glucose metabolism but do not directly support liver function or energy production
Individual results vary, and outcomes on compounded GLP-1 preparations may differ from outcomes documented in clinical trials using brand-name FDA-approved formulations
Why is it so much more expensive in the US
Investigators revealed over 300 beauty salons currently offering these invasive procedures, often without medical supervision, proper hygiene, or safety protocols, and promoting them on social media to vulnerable audiences